Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Other Working Capital Changes: 2013-2025

Historic Other Working Capital Changes for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $956,000.

  • Veracyte's Other Working Capital Changes rose 164.46% to $956,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $39.6 million, marking a year-over-year increase of 886.97%. This contributed to the annual value of -$5.4 million for FY2024, which is 24.87% down from last year.
  • As of Q3 2025, Veracyte's Other Working Capital Changes stood at $956,000, which was down 62.24% from $2.5 million recorded in Q2 2025.
  • Veracyte's Other Working Capital Changes' 5-year high stood at $33.2 million during Q4 2024, with a 5-year trough of -$5.8 million in Q3 2023.
  • Moreover, its 3-year median value for Other Working Capital Changes was $956,000 (2025), whereas its average is $2.9 million.
  • The largest annual percentage gain for Veracyte's Other Working Capital Changes in the last 5 years was 3,104.52% (2024), contrasted with its biggest fall of 870.79% (2024).
  • Veracyte's Other Working Capital Changes (Quarterly) stood at $1.4 million in 2021, then tumbled by 162.23% to -$878,000 in 2022, then fell by 25.85% to -$1.1 million in 2023, then soared by 3,104.52% to $33.2 million in 2024, then soared by 164.46% to $956,000 in 2025.
  • Its last three reported values are $956,000 in Q3 2025, $2.5 million for Q2 2025, and $2.9 million during Q1 2025.